Cargando…

Bone Turnover in Azerbaijani Patients with Type 2 Diabetes

Detalles Bibliográficos
Autor principal:	SAFAROVA, Sain Sattar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719644/ https://www.ncbi.nlm.nih.gov/pubmed/33346229 http://dx.doi.org/10.18502/ijph.v49i10.4711

Ejemplares similares

Bone Metabolism Parameters in Azerbaijani Pre and Postmenopausal Women with Diabetes
por: Safarova, Sain Sattar
Publicado: (2023)

Orchids of Azerbaijani Cemeteries
por: Molnár V., Attila, et al.
Publicado: (2021)

Alterations of Bone Metabolism in Patients with Diabetes Mellitus
por: Safarova, Sain S.
Publicado: (2019)

Genotype-Phenotype Correlations of β-Thalassemia Mutations in an Azerbaijani Population
por: Asadov, Chingiz, et al.
Publicado: (2017)

The association between bone turnover markers and microvascular complications of type 2 diabetes
por: Maghbooli, Zhila, et al.
Publicado: (2016)

Low Turnover Bone Disease in Early CKD Stages
por: Barreto, Fellype Carvalho, et al.
Publicado: (2022)

Life events impact on experiences of COVID-19 pandemic (in Azerbaijani sample)
por: Ismailova, E., et al.
Publicado: (2022)

Effects of Raloxifene on Bone in Patients With Type 2 Diabetes
por: Gorai, Itsuo
Publicado: (2012)

Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022)

Distribution of Hepatitis B Virus Genotypes in Azerbaijani Patients With Chronic Hepatitis B Infection
por: Bokharaei-Salim, Farah, et al.
Publicado: (2014)

Association Analysis of Triglyceride Glucose-Body Mass Index and Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus [Letter]
por: Mo, Jianming, et al.
Publicado: (2023)

Distribution of Hepatitis C Virus Genotypes Among Azerbaijani Patients in Capital City of Iran-Tehran
por: Bokharaei-Salim, Farah, et al.
Publicado: (2013)

Investigation of the DNMT3B –579 G>T Promoter Polymorphism in Patients with Colorectal Cancer in an Azerbaijani Population
por: Bayramov, Bayram, et al.
Publicado: (2022)

Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure
por: He, Tianlin, et al.
Publicado: (2021)

Type 2 diabetes affects bone cells precursors and bone turnover
por: Sassi, Francesca, et al.
Publicado: (2018)

Bone turnover and bone mineral density in old persons with type 2 diabetes
por: Martins, João Martin, et al.
Publicado: (2018)

The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes
por: Xiao, Wen-hua, et al.
Publicado: (2013)

Mutation analysis of the phenylalanine hydroxylase gene in Azerbaijani population, a report from West Azerbaijan province of Iran
por: Bagheri, Morteza, et al.
Publicado: (2015)

Micronutrient Deficiencies, Over- and Undernutrition, and Their Contribution to Anemia in Azerbaijani Preschool Children and Non-Pregnant Women of Reproductive Age
por: Wirth, James P., et al.
Publicado: (2018)

Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH
por: Vavanikunnel, Janina, et al.
Publicado: (2022)

Extracellular Matrix Turnover: a Balance between MMPs and their Inhibitors
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

The Relationships Between Glycated Hemoglobin and Bone Turnover Markers in Patients with Type 2 Diabetes but No Diabetic Nephropathy
por: Zhao, Hang, et al.
Publicado: (2022)

Prophylactics of Type 2 Diabetes and Diabetic Foot
por: Vakrilova Becheva, Maria S., et al.
Publicado: (2022)

Association of Glycemic Status with Bone Turnover Markers in Type 2 Diabetes Mellitus
por: Kulkarni, Sweta Vilas, et al.
Publicado: (2017)

Glycemic Control and Bone Turnover in Older Mexican Americans with Type 2 Diabetes
por: Rianon, Nahid J., et al.
Publicado: (2018)

The association between normal serum sodium levels and bone turnover in patients with type 2 diabetes
por: Huang, Hai-yan, et al.
Publicado: (2022)

Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions
por: Rubin, Mishaela R, et al.
Publicado: (2016)

Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?
por: Bernardi, Marco, et al.
Publicado: (2023)

Mehamudgaravati and type 2 diabetes mellitus
por: Wiwanitkit, Viroj
Publicado: (2011)

The HIV Associated Type 2 Diabetes
por: Kasthuri, A, et al.
Publicado: (2014)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
por: Gracia‐Ramos, Abraham Edgar
Publicado: (2019)

Thyroid and bone turnover markers in type 2 diabetes: results from the METAL study
por: Chen, Yi, et al.
Publicado: (2022)

Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes
por: Maser, Raelene E., et al.
Publicado: (2008)

Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis”
por: Jørgensen, Hanne Skou, et al.
Publicado: (2022)

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Albugami, Muneerah M., et al.
Publicado: (2020)

Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
por: Liu, X. X., et al.
Publicado: (2020)

Vitamin D is associated with blood lead exposure through bone turnover in type 2 diabetes patients
por: Zhang, Haojie, et al.
Publicado: (2021)

Corrigendum: The association between normal serum sodium levels and bone turnover in patients with type 2 diabetes
por: Huang, Hai-yan, et al.
Publicado: (2022)

Bariatric surgery on type 2 diabetes: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7v1vijhjqhho8mh1rdb79ohav9